Whoop is accelerating its expansion into clinical-grade health insights with the launch of Specialized Panels, a new range of targeted blood tests designed to deliver deeper, more personalized data across key areas of wellness.
The $299 panels mark the latest step in the company’s broader strategy to evolve from a fitness tracker into what it describes as a “health operating system.” The new offering builds on Whoop’s Advanced Labs platform, introduced in 2025 in partnership with Quest Diagnostics, which combines lab testing with continuous data from its wearable device.
With the introduction of Specialized Panels, Whoop is shifting toward more focused and customizable analysis. Each panel evaluates between 75 and 89 biomarkers, covering five major categories: heart health, performance, metabolic health, women’s health and men’s health. The tests are available as one-time purchases, do not require a subscription and are eligible for FSA and HSA spending.
The move reflects a growing trend in the wearables sector, where companies are increasingly integrating clinical data with real-time biometric tracking. By pairing lab results with continuous monitoring – such as heart rate, sleep and recovery metrics – platforms like Whoop aim to provide a more comprehensive view of an individual’s health.
Early data from Whoop’s Advanced Labs suggests strong demand for deeper insights. According to the company, 22% of its highly active users show signs of metabolic dysfunction, while nearly 30% have underlying cardiometabolic risk factors, often without prior awareness. These findings are helping to drive interest in more targeted testing options.
Competition in the space is intensifying. Oura has introduced its own health panels in collaboration with Quest Diagnostics, offering access to around 50 biomarkers with results integrated directly into its app alongside AI-driven recommendations. Meanwhile, Vida Health is working with Oura to incorporate wearable data into clinical care programs, giving healthcare providers continuous visibility into key health signals.
Whoop’s latest expansion underscores a broader shift in digital health – where wearable devices are no longer just tracking activity, but increasingly acting as gateways to medical-grade insights and preventative care.
As the line between consumer fitness and clinical healthcare continues to blur, companies like Whoop are betting that users will embrace more proactive, data-driven approaches to managing their long-term health.
